MRK Financial Facts
Net Income Attributable to Merck & Co., Inc.: 7.95BTaxes on Income: 2.75B
See Full Income Statement
Dividends payable: 0
Other Assets: 5.15B
See Full Balance Sheet
Merck & Co. Inc. (MRK) Earnings
|
Expand Research on MRK
| Next EPS Date | 10/29/26 | EPS Growth Rate | -14.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +18.8% | Revenue Growth Rate | +0.2% |
| Average % Move 1-Wk after EPS | +1.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/29/26  |
Q326 | N/A | $2.22 | N/A | N/A | $17.31B | = | N/A | N/A | ||
| 8/4/26 | Q226 | -$0.13 | -$0.27 | +$0.14 | $16.6B | $16.41B | = |  | | Details | |
| 4/30/26 | Q126 | -$1.28 | -$1.48 | +$0.20 | $16.29B | $15.89B | = | | | Details | |
| 2/3/26 | Q425 | $2.04 | $2.04 | $0.00 | $16.4B | $16.18B | = | | | Details | |
| 10/30/25 | Q325 | $2.58 | $2.35 | +$0.23 | $17.28B | $16.98B | = | | | Details | |
| 7/29/25 | Q225 | $2.13 | $2.03 | +$0.10 | $15.81B | $15.87B | = | | | Details | |
| 4/24/25 | Q125 | $2.22 | $2.14 | +$0.08 | $15.53B | $15.33B | = | | | Details | |
| 2/4/25 | Q424 | $1.72 | $1.81 | -$0.09 | $15.6B | $15.47B | = | | | Details |
